Normal Values of Circulating Insulin-Like Growth Factor-I Bioactivity in the Healthy Population: Comparison with Five Widely Used IGF-I Immunoassays | Zendy

Michael P. Brugts | Zendy; Michael B. Ranke | Zendy; Leo J. Hofland | Zendy; Katy van der Wansem | Zendy; Karin Weber | Zendy; Jan Frystyk | Zendy; Steven W. J. Lamberts | Zendy; J. A. M. J. L. Janssen | Zendy

Open Access

Normal Values of Circulating Insulin-Like Growth Factor-I Bioactivity in the Healthy Population: Comparison with Five Widely Used IGF-I Immunoassays

Author(s) -

Michael P. Brugts,

Michael B. Ranke,

Leo J. Hofland,

Katy van der Wansem,

Karin Weber,

Jan Frystyk,

Steven W. J. Lamberts,

J. A. M. J. L. Janssen

Publication year - 2008

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-2454

Subject(s) - insulin like growth factor , normative , growth factor , population , medicine , endocrinology , receptor , political science , environmental health , law

IGF-I immunoassays are primarily used to estimate IGF-I bioactivity. Recently an IGF-I-specific kinase receptor activation assay (KIRA) has been developed as an alternative method. However, no normative values have been established for the IGF-I KIRA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research